Publications by authors named "Amal Zubani"
Article Synopsis
- This study investigates the effects of using nirsevimab, a long-acting monoclonal antibody, for universal immunoprophylaxis against respiratory syncytial virus (RSV) in infants during their first RSV season in Saudi Arabia.
- The research utilized a decision-analytic model to compare the healthcare burden and costs associated with RSV under current practices vs. the implementation of nirsevimab, estimating significant reductions in hospitalizations, emergency visits, and healthcare costs.
- Findings suggest that nirsevimab could reduce RSV-related hospitalizations by 58%, avoid numerous medical visits, prevent deaths, and save between SAR 274-343 million, indicating a substantial positive impact on both healthcare
Objectives: This study aimed to describe the incidence and spectrum of postoperative complications in infants who underwent their first cardiac surgery for the repair of congenital heart diseases.
Methods: This is a single-center retrospective study. Data of infants admitted to King Faisal Specialist Hospital & Research Center; Jeddah; Saudi Arabia, from January 2015 to December 2019 who underwent the first cardiac procedure for congenital heart disease at an age of less than 3 months, were analyzed.